Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 19 ... or breakdown of ACh within cholinergic synapses. The acetylcholinesterase inhibitor, neostigmine, and the 5-HT(4) receptor partial agonist tegaserod, are two agents with known ...
2009 AUG 31 ... New investigation results, 'The effects of neostigmine and glycopyrrolate on skin conductance as a measure of pain,' are detailed in a study ...
2009 FEB 23 ... cheese incisional hernia at the site of previous surgery. After the administration of neostigmine and glycopyrrolate, she developed a generalized rash without any hemodynamic ...
2009 MAR 16 ... the level of neuromuscular block is not intense. As little as 0.015-0.025 mg.kg(-1) of neostigmine is required at a train-of-four count of four with minimal fade, whereas 0.04-0.05 ...
2009 NOV 16 ... acid (AA) and cyclophosphamide (CYP). The effects of intrathecal (i.t.) application of neostigmine as an acetylcholine esterase (AChE) inhibitor, oxotremorine-M (OXO-M) as a muscarinic ...
2009 SEP 7 ... According to a study from the United States, "Intrathecal neostigmine not only produces analgesia but also severe nausea. In contrast, epidural...
2009 MAR 10 ... or deep NMB, thus eliminating the need for acetylcholinesterase inhibitors such as neostigmine and cholinergic antagonists such as glycopyrrolate or atropine. Clinical trials have ...
2009 SEP 8 ... and Physiology, "Cholinergic agonists and acetylcholinesterase inhibitors, such as neostigmine, produce a muscarinic receptor-mediated antinociception in several animal species that ...
2009 JUN 29 ... to examine the relationships among neuromuscular blockade, reversal agent use (including neostigmine, pyridostigmine, and edrophonium), and elapsed OR time by controlling for age, gender, ...
2009 APR 20 ... and sinus rhythm in the isolated right atrium preparation of rat with those of armin and neostigmine. Both armin (10(-7), 10(-6), and 10(-5) M) and...
2009 FEB 23 ... receptor agonist which also facilitates GI cholinergic function."
"Neostigmine greatly increased EFS-evoked contractions over a narrow concentration range (0.01-1 mu ...
2009 JUL 13 ... the actions of 5-OHIP but not the excitatory activity of the cholinesterase inhibitor neostigmine. In summary, the present data demonstrate an interaction of '5-HT(1P)-ligands' with ...
2009 NOV 2 ... are important for its the beneficial effect. Other adjuvants, except neuraxial low-dose neostigmine, are of minor importance. Opioids and alpha-2 receptor agonists are important as ...
2009 AUG 3 ... the actions of 5-OHIP but not the excitatory activity of the cholinesterase inhibitor neostigmine. In summary, the present data demonstrate an interaction of '5-HT1P-ligands' with the ...
2009 OCT 26 ... Immediately after rocuronium infusion was discontinued, the time required for 0.04 mg/kg neostigmine-facilitated recovery to a TOF ratio of 0.9 was recorded. Rocuronium infusion dose after ...
2009 OCT 5 ... The effects of intracerebroventricular (i.c.v.) or intrathecal (i.t.) administration of neostigmine as a cholinesterase inhibitor and oxotremorine-M (OXO-M) as a muscarinic acetylcholine ...
2009 MAR 10 ... the cholinergic neurotransmission in the OB by addition of the anticholinesterase drug neostigmine (20 mM) sharpened the ORF responses of mitral cells. Furthermore, coaddition of either ...
2009 MAR 9 ... therapy. Controlled clinical trials have shown that the acetylcholinesterase inhibitor neostigmine is an effective treatment with initial response rates of 60-90 per cent; other drugs for ...
